Home Gastrointestinal Canadian Province Expands Biosimilar Switching, But Patient Group Voices Concerns – Generics...

Canadian Province Expands Biosimilar Switching, But Patient Group Voices Concerns – Generics Bulletin

115
0

Canadian Province Expands Biosimilar Switching, But Patient Group Voices Concerns  Generics Bulletin

British Columbia’s move to switch gastrointestinal patients to biosimilar infliximabs by March 2020 has pleased local industry but upset an originator-backed …

This site uses Akismet to reduce spam. Learn how your comment data is processed.